Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation
- Conditions
- Atrial FibrillationLeft Atrial Appendage LigationPericardiumEpicardial MappingHeart AtriaCardiac Surgical ProceduresCardiac CatheterizationPneumopericardiumLeft Atrial Appendage Occlusion
- Interventions
- Procedure: Pericardial insufflation with carbon dioxide through a transatrial microcatheter
- Registration Number
- NCT06584370
- Lead Sponsor
- Henry Ford Health System
- Brief Summary
We use a tiny catheter through the heart to separate the pericardium with gas. We expect this to improve the safety of the Lariat procedure.
- Detailed Description
The Lariat suture device enables non-surgical exclusion of the left atrial appendage possibly to prevent thromboembolism and stroke in patients with atrial fibrillation. Subxiphoid needle access to the pericardium (a standard approach to enter the pericardial space surrounding the heart using a needle underneath the breastbone) during Lariat risks injury to the heart surface that requires surgical repair.
In this protocol the investigators propose test a new method to increase the safety of needle access to the pericardium. Before needle access, the investigators introduce a separate tiny catheter into the pericardium from inside the heart through a tiny hole. The investigators then inject gas to push the heart away from the pericardial needle. This reduces the risk of injuring the heart during the standard Lariat procedure.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 13
- Undergoing subxiphoid access to the "empty" pericardial space as part of a Lariat left atrial appendage exclusion procedure
- Age ≥ 21 years
• Does not consent to participate
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Pericardial insufflation with CO2 Pericardial insufflation with carbon dioxide through a transatrial microcatheter Intentional transatrial introduction of a microcatheter to insufflate the pericardium with carbon dioxide, to separate the walls of the pericardium
- Primary Outcome Measures
Name Time Method Successful subxiphoid needle access without myocardial injury Immediate
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Henry Ford Health System
🇺🇸Detroit, Michigan, United States